Mapp Biopharmaceutical (United States)

Mapp Biopharmaceutical (United States)

Mapp Biopharmaceutical is an American pharmaceutical company founded in 2003 by Larry Zeitlin and Kevin Whaley. Mapp Biopharmaceutical is based in San Diego, California. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Mapp Biopharmaceutical (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

77%


Total
Publications

159


Total Open
Publications

123


Total
Citations

6.6K


Open Access
Percentage

77%


Total
Publications

159


Total Open
Publications

123


Total
Citations

6.6K

Wikipedia

Website

download

Breakdown

18% 41% 17% 24%

Publisher Open

18%

Both

41%

Other Platform Open

17%

Closed

24%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618202224Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

53%OA Journal

OA Journal 53%

46

Hybrid 22%

19

No Guarantees 25%

22

Other Platform Open

Domain 85%

73

Other Internet 15%

13

Institution 12%

10

Public 3%

3

Preprint 2%

2

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
73
DOI
Other Internet
13
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI
Institution
3
Figshare
Public
3
Europe PMC
Domain
3
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
2
Washington University School of Medicine - Digital Commons@Becker
Institution
1
University of Pretoria - UpSpace Institutional Repository
Institution
1
University of Cagliari - UNICA IRIS Institutional Research Information System
Institution
1
University of Bristol - Bristol Research
Institution
1
1 / 2

Data updated 18 August 2025

Share

Share

Share